Building Blocks

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>7-Bromo-3,4-dihydroquinazolin-2(1H)-one is a new atypical antipsychotic. It has been shown to have 5-HT1A receptor antagonist activity, and d2 receptor agonist activity. 7-Bromo-3,4-dihydroquinazolin-2(1H)-one has been shown to be an effective agent for the treatment of schizophrenia in animal models. This drug has also been shown to have antidepressant effects in rats, suggesting that it may have additional therapeutic effects. The mechanism of 7-bromo 3,4 dihydroquinazolin-2(1H) one is not fully understood but is thought to involve the reduction of quinazoline by reductive amination with tertiary amines followed by cyclization with piperazine or other heterocycles.</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>6-Benzyl-2,4-dichloro-5H-pyrrolo[3,4-d]pyrimidin-7-one is a difluorinated pyrrolopyrimidine with a carbonyl group. It has a molecular weight of 180.8 g/mol and the chemical formula C14H12Cl2F2N2O. The compound is an asymmetric molecule that crystallizes as chains. Its crystal structure is made up of two stacked chains with dihedral angles of approximately -90° and -45°, which are stabilized by hydrogen bonds. The planarity of the molecule's carbonyl group is disordered because it does not have any planar groups.</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>CRT0066101 is a protein kinase inhibitor that has shown to be effective in inhibiting the growth of cancer cells. CRT0066101 inhibits the activity of HER2+ breast cancer cells by binding to and blocking the function of protein kinases, which are enzymes that regulate cell growth. The mechanism of action for CRT0066101 is not fully understood but it may be due to its ability to inhibit protein synthesis or block the activation of transcription factors. CRT0066101 also blocks the proliferation of HER2+ breast cancer cells in an experimental model and has shown efficacy against other types of cancers including pancreatic and colorectal cancers. This drug is currently undergoing clinical trials for use as an anti-cancer treatment.</p>

<p>Versatile small molecule scaffold</p>

<p>dBET57 is a molecule that targets the ubiquitin-proteasome system (UPS) by linking the ubiquitin protein to the proteasome. It has been shown that dBET57 binds to bromodomains and modulates gene expression in cancer cells, inhibiting cell growth. The e3 ubiquitin ligase can also be inhibited by dBET57 through binding to its target site. This leads to lysis of cancer cells and induces autophagy, which is an important cancer therapy.</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>N-(2-Indanyl)aniline is a quaternary ammonium salt that has antiarrhythmic properties. It is used for the treatment of arrhythmias, such as ventricular tachycardia or ventricular fibrillation, and can be administered intravenously or orally. N-(2-Indanyl)aniline is a type of quaternary ammonium salt with antiarrhythmic properties. It can be administered intravenously or orally. The chemical structure of this drug contains an amine group and a quaternary ammonium group, which are both positively charged. This drug is used to treat arrhythmias, such as ventricular tachycardia or ventricular fibrillation.</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>4-Chloropyridine-3-sulfonyl chloride is a thrombin inhibitor that has been discovered through the use of in vitro screening methods. It is a small molecule with lipophilic properties and oral bioavailability. This compound inhibits thrombin by binding to the active site of the enzyme, which prevents the formation of an enzyme-thrombin complex. The discovery was made using a pharmacophore-based approach and further modifications were made to improve its potency and increase its lipophilicity. This compound also exhibits an acceptable level of bioavailability in vivo, which may be due to its high solubility in water.</p>

<p>1-(2-Nitrophenyl)pyrrole (1-NPyr) is an activated form of pyrrole that is synthesized by the Saccharomyces cerevisiae strain. It can be reduced with borohydride to produce 1-aminonitrobenzene. 1-NPyr has been shown to be used as a precursor for the synthesis of various drugs, including multidrugs and anilines. This compound is enantiopure and thermodynamically stable, making it an ideal candidate for asymmetric synthesis.</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>1-Bromo-8-methylnaphthalene is a synthetic chemical that belongs to the group of butyric acid derivatives. It has been shown to react reversibly with alcohols and carbonyls, as well as iodides and cinnamic acids. 1-Bromo-8-methylnaphthalene can be synthesized from xylene using lithium diisopropylamide (LDA) in the presence of an amine base, yielding a mixture of products, including oxetane. This compound crystallizes in space group P2(1)/c with unit cell dimensions a = 12.7 Å, b = 14.4 Å, c = 18.5 Å, β = 98.1° and Z = 2.</p>

<p>1-Chloro-3-(prop-2-yn-1-yloxy)benzene is a ligand that can be used in supramolecular chemistry. This ligand interacts with anionic polymers and forms a coordination polymer. The interaction of the ligand and the polymer leads to self-assembly, which is the formation of large structures from small units or molecules. 1-Chloro-3-(prop-2-yn-1-yloxy)benzene has been shown to form silver clusters, which are aggregates of metal atoms held together by relatively weak forces.</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>3-Hydroxy-1-methylpiperidin-2-one is an organic compound that can be used as a chiral building block in the synthesis of enantiomerically pure compounds. It is a racemic mixture that is obtained by reacting 3-hydroxy-1,2-dimethylpiperidinium chloride with sodium methoxide. The lipase activity of Pseudomonas cepacia has been immobilized on a solid support in order to produce enantioselective synthesis. This immobilization prevents the enzyme from being washed out during the reaction process and provides a continuous supply of active enzyme. The enantioselective synthesis of 3-hydroxy-1,2-dimethylpiperidinium chloride has been achieved using chemoenzymatic methods.</p>

<p>5-Hydroxy-1-methylpiperidin-2-one is a muscle relaxant that is used as a medicine. This drug has been shown to have an inhibitory effect on bacterial growth and may be used for the treatment of infections caused by bacteria, such as tuberculosis. 5-Hydroxy-1-methylpiperidin-2-one binds to the histamine H1 receptor and inhibits the release of histamine, which may reduce pain and inflammation. This drug also has anticancer properties. 5HMP binds to DNA in the G protein coupled receptors and prevents them from binding to their corresponding ligands. It also inhibits cell proliferation by inhibiting protein synthesis, which leads to cell death by apoptosis or necrosis.</p>

<p>2-Chloro-5-methylthiazole is a chlorinating agent that can be used to synthesize organic compounds. It is prepared by the reaction of triethylamine solution and acetonitrile in the presence of hydrochloric acid and hexane. The synthesis temperature should be kept below -10°C. The product is isolated by filtration, washed with diluent (e.g., isopropyl), and dried under vacuum. 2-Chloro-5-methylthiazole reacts with chloride to produce chlorine gas, which can then be purified using a solution of hydrochloric acid in hexane or methylthiazole in acetonitrile.<br>2-Chloro-5-methylthiazole can also react with sodium metal in an ethereal solution to produce methylene chloride, which is then reacted with ammonia to form methylamine.</p>

<p>Versatile small molecule scaffold</p>

<p>2-Pentylpiperidine is an acetylcholine receptor agonist and is also a toxic alkaloid. It is biosynthesized in animals by the hydroxylation of butyrolactone. 2-Pentylpiperidine has been shown to have antinociceptive effects in animals, which may be due to its ability to activate nicotinic acetylcholine receptors. 2-Pentylpiperidine has also been shown to inhibit the growth of cells in culture, and also inhibits the production of cyclohexanol from cyclohexanone. This drug has been shown to cause death in humans at high doses, with several possible causes being considered: inhibition of protein synthesis or cell division, or interference with RNA synthesis.</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>5-Methyl-2-thioxoimidazolidin-4-one (MTI) is an antibacterial agent that has been shown to have a strong inhibitory effect against Staphylococcus epidermidis. MTI has been shown to be an effective antidiabetic, pesticide, and antibacterial agent. It also has a tautomeric form that reversibly binds to the active site of bacterial DNA topoisomerase II, which prevents the rewinding of DNA and inhibits transcription. MTI is used in the treatment of mammalian cells for cancer treatment. In addition, it can alkylate DNA bases and disrupts the DNA replication process.</p>